Increased Janus kinase activation in cutaneous vasculitis.

Ebata, Aoi; Ogawa-Momohara, Mariko; Fukaura, Ryo; Yamashita, Yuta; Koizumi, Haruka; Takeichi, Takuya; Muro, Yoshinao; Akiyama, Masashi

Ebata, Aoi; Ogawa-Momohara, Mariko; Fukaura, Ryo; Yamashita, Yuta; Koizumi, Haruka; Takeichi, Takuya; Muro, Yoshinao; Akiyama, Masashi.

Afiliación

Ebata A; Department of Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Ogawa-Momohara M; Department of Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan. Electronic address: marikkori0910@gmail.com.
Fukaura R; Department of Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Yamashita Y; Department of Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Koizumi H; Department of Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Takeichi T; Department of Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Muro Y; Department of Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Akiyama M; Department of Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

J Am Acad Dermatol ; 90(3): 627-629, 2024 Mar.

Article en En | MEDLINE | ID: mdl-37924954

Asunto(s)

Enfermedades Cutáneas Vasculares; Vasculitis Leucocitoclástica Cutánea; Humanos

Palabras clave

IgA vasculitis; Janus kinase (JAK) inhibitors; cutaneous leukocytoclastic vasculitis; immunohistochemical analysis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedades Cutáneas Vasculares / Vasculitis Leucocitoclástica Cutánea Límite: Humans Idioma: En Revista: J Am Acad Dermatol Año: 2024 Tipo del documento: Article País de afiliación: Japón

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google